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Summary
The vast majority of fragile-X full mutations are heavily
methylated throughout the expanded CGG repeat and
the surrounding CpG island. Hypermethylation initiates
and/or stabilizes transcriptional inactivation of the
FMR1 gene, which causes the fragile X–syndrome phe-
notype characterized, primarily, by mental retardation.
The relation between repeat expansion and hyperme-
thylation is not well understood nor is it absolute, as
demonstrated by the identification of nonretarded males
who carry hypomethylated full mutations. To better
characterize the methylation pattern in a patient who
carries a hypomethylated full mutation of ∼60–700 re-
peats, we have evaluated methylation with the McrBC
endonuclease, which allows analysis of numerous sites
in the FMR1 CpG island, including those located within
the CGG repeat. We report that the expanded-repeat
region is completely free of methylation in this full-mu-
tation male. Significantly, this lack of methylation ap-
pears to be specific to the expanded FMR1 CGG-repeat
region, because various linked and unlinked repetitive-
element loci are methylated normally. This finding dem-
onstrates that the lack of methylation in the expanded
CGG-repeat region is not associated with a global defect
in methylation of highly repeated DNA sequences. We
also report that de novo methylation of the expanded
CGG-repeat region does not occur when it is moved via
microcell-mediated chromosome transfer into a de novo
methylation-competent mouse embryonal carcinoma
cell line.
Received June 29, 1999; accepted for publication August 30, 1999;
electronically published October 5, 1999.
Address for correspondence and reprints: Dr. Bradley W. Popovich,
DNA Diagnostic Lab, CDRC 2254, Oregon Health Sciences Univer-
sity, 707 S.W. Gaines Road, Portland, OR 97201. E-mail: popovich
@ohsu.edu
 1999 by The American Society of Human Genetics. All rights reserved.
0002-9297/1999/6505-0020$02.00
Introduction
Fragile-X syndrome (MIM 309550) is an X-linked men-
tal retardation disorder with an incidence of ∼1/6,000
(Turner et al. 1996; de Vries et al. 1997; Morton et al.
1997). In most patients, amplification of an unstable
CGG repeat, located in the 5′ untranslated region of the
FMR1 gene, is responsible for the syndrome (Kremer et
al. 1991; Oberle et al. 1991; Verkerk et al. 1991; Yu et
al. 1991). In the normal population, FMR1 alleles con-
tain 5–∼55 repeats, are stable on transmission, and are
not methylated except when located on an inactive X
chromosome in females (Bell et al. 1991; Fu et al. 1991;
Hansen et al. 1992; Hornstra et al. 1993). Premutation
alleles with ∼55–∼220 repeats are found in unaffected
carriers and, like normal alleles, are not methylated un-
less they are located on an inactive X chromosome.
When transmitted by a woman, premutation alleles can
expand to become disease-causing full mutations (Fu et
al. 1991; Heitz et al. 1991; Oberle et al. 1991; Snow et
al. 1993).
Full-mutation alleles contain from ∼220 to 11,000
repeats and are almost always associated with extensive
hypermethylation of the CGG repeat and a surrounding
CpG island (Heitz et al. 1991; Oberle et al. 1991; Pieretti
et al. 1991; Hansen et al. 1992; Sutcliffe et al. 1992;
Hornstra et al. 1993). Hypermethylation of promoter
elements (Pieretti et al. 1991; Sutcliffe et al. 1992) and
histone deacetylation (Coffee et al. 1999) are associated
with transcriptional silencing of the FMR1 gene, pre-
sumably by interfering with transcription-factor binding
(Schwemmle et al. 1997). The resulting lack of FMR1
protein (FMRP) is believed sufficient to cause the fragile
X–syndrome phenotype (Pieretti et al. 1991; Devys et
al. 1993; Siomi et al. 1993; Hammond et al. 1997).
Although repeat expansions 1 ∼220 triplets are typically
accompanied by hypermethylation, unusual expansions
have been described in which full-mutation alleles are
unmethylated at diagnostic restriction sites (Loesch et
al. 1993; McConkie-Rosell et al. 1993; Hagerman et al.
1994; Merenstein et al. 1994; Rousseau et al. 1994b;
Smeets et al. 1995; de Vries et al. 1996; Lachiewicz et
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Figure 1 No methylation at EagI site. A, Simplified restriction
map of the region surrounding the FMR1 CGG repeats. The size of
the restriction fragments are determined on the basis of a normal allele
with 30 repeats. The probe used was pfxa3. B, Southern blot of ge-
nomic DNA samples digested with EcoRI/EagI and hybridized with
pfxa3.A control female (lane 2) showing amethylated 5.2-kb fragment
resistant to EagI digestion (inactive X chromosomes) and an unme-
thylated 2.8-kb fragment that is digested with EagI (active X chro-
mosomes). Three DNA samples from the patient (lanes 3–5): two
peripheral blood–lymphocyte samples collected in 1994 and 1997
(pbl’94 and pbl’97, respectively) and cultured fibroblasts established
from a 1997 skin biopsy (fibro’97). The approximate CGG-repeat
number, as a function of size for unmethylated alleles, is shown on
the left.
al. 1996; Wang et al. 1996; Wohrle et al. 1998; Taylor
et al. 1999). Male carriers of these mutations are often
described as “high-functioning” and can have cognitive
and physical phenotypes in the normal-to-mild range of
affectedness. FMRP expression has been reported in
many of these patients, although at levels reduced rel-
ative to that of normal controls. This reduction may be
a result of translational suppression (Feng et al. 1995).
FMR1 methylation, in these individuals, has been stud-
ied with use of methylation-sensitive restriction endon-
ucleases, which limit the number of methylation sites
that can be analyzed. Although FMRP expression sug-
gests that regulatory elements are also unmethylated, the
methylation status of most sites in the CpG island, in-
cluding the expanded CGG repeat, have not been
described.
The association between repeat expansion and meth-
ylation is not well understood, and, in particular, it is
unknown why some full-mutation alleles escape the
methylation process. Reports of typically methylated full
mutations in the grandsons of males bearing hypome-
thylated full mutations favor a role for trans-acting fac-
tors rather than a heritable cis effect (Smeets et al. 1995;
Lachiewicz et al. 1996; Wohrle et al. 1998). The study
of methylation variants at the fragile-X locus will help
define the basic relation between repeat expansion and
methylation and may also provide information about
the potential efficacy of therapeutic approaches that util-
ize demethylating agents (Chiurazzi et al. 1994). More-
over, a description of FMR1 methylation in hypome-
thylated full-mutation males is a necessary prerequisite
for the study of the proposed influence of methylation
on repeat stability (Wohrle et al. 1996).
The aims of the present study were to confirm that
hypomethylation at the diagnostic EagI site extends into
the expanded CGG-repeat region and to ascertain
whether this lack of methylation is indicative of a trans
defect in de novo and/or maintenance methylation. We
have assessed methylation at a large number of sites in
the FMR1 CpG island, including the CGG repeat, and
at various repetitive DNA elements. Our data demon-
strate an absence of methylation throughout the CpG
island, despite normal methylation levels at flanking Alu
elements and at other repetitive-element loci. The meth-
ylation deficit in the expanded CGG-repeat region was
not corrected when the human X chromosome carrying
this allele was transferred into a de novo methylation-
competent mouse cell line. These results argue against a
model in which hypomethylation of full mutation FMR1
alleles is a result of a trans defect in DNA methylation.
Patient and Methods
Patient Description
M.K. is a 39-year-old male who was evaluated for a
fragile-X mutation on the basis of a positive family his-
tory. M.K.’s sister, mother, and maternal aunt are known
to be premutation carriers. The maternal aunt has two
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sons who are both reported to carry fragile-X full mu-
tations. One cousin is reported to be mentally retarded
and to carry a typical methylated full mutation. The
other cousin, like M.K., is reported to carry an unmeth-
ylated or partially unmethylated full mutation. In ad-
dition, M.K. has six other siblings, all of whom carry
FMR1 alleles in the normal size range.
Cognitively, M.K. appears to be quite “high-function-
ing.” He graduated from high school and is raising a
family with two sons. He has been in the military where
he successfully completed specialized training. He is cur-
rently employed as a drug and alcohol counselor. M.K.
has good eye contact and comfortably engages in con-
versation. On the basis of a short interview that did not
include a physical evaluation or formal cognitive testing,
he does not appear to be affected with the fragile-X
syndrome either cognitively or behaviorally.
DNA Isolation and Analysis
Genomic DNA was isolated with use of either a stan-
dard phenol/chloroform extraction or the Puregene
DNA Isolation Kit (Gentra Systems). Aliquots (10–30
mg) were digested with restriction endonucleases pur-
chased either from Boehringer Manheim (EcoRI, PstI,
MspI, and HindIII) or New England Biolabs (EagI,
McrBC, HpaII, and BstBI). EcoRI/EagI double digests
were performed simultaneously with both enzymes. All
other double digestions were performed sequentially
with an initial digestion using PstI, EcoRI, or HindIII,
followed by precipitation, and then a second digestion
with McrBC, MspI, HpaII, or BstBI. Digested DNA was
precipitated with sodium acetate and ethanol, and then
aliqouts of 1.5–2.5 mg were separated by elecrophoresis
onto a 1% agarose/TAE gel and transferred to Biodyne
B nylon membrane (Gibco BRL) with 5 # SSC. Hy-
bridizations with a 32P-radiolabelled probe (Boehringer
Manheim; Random Prime Labelling Kit) were carried
out at 65C in Church Buffer with BSA (hybridization
buffer II) (Strauss 1998), supplemented with 100 mg/ml
heat-denatured herring spermDNA. Probe pfxa3 (a kind
gift from David L. Nelson, Baylor College of Medicine,
Houston), a 558-bp XhoI/PstI fragment of pE5.1 (fig.
1A) (Fu et al. 1991; Verkerk et al. 1991), was used to
detect restriction fragments containing the CGG repeat.
Additional probes used to assess methylation at the re-
petitive-element loci are described below. Membranes
were washed twice at room temperature in low-strin-
gency wash buffer II (Strauss 1998) and then twice at
68.5C in high-stringency wash buffer II (Strauss 1998),
diluted to 60%. Membranes were exposed sequentially
to a phosphorimaging screen (Molecular Dynamics) and
then to X-ray film (Kodak; X-OMAT) at 70C.
Analysis of Repetitive DNA–Element Methylation
Repetitive-element loci were identified in genomic
DNA sequence with the RepeatMasker database. The
Alu elements flanking the FMR1 CGG repeat, as well
as the L1 and SVA (sindbis virus) elements, are contained
in the “HUMFMR1S DNA sequence” (Genbank acces-
sion number L29074). The positions of the Alu, L1, and
SVA elements within the L29074 sequence are as fol-
lows: the Alu element upstream of FMR1 CGG repeat
(nucleotides 7984–8274), the Alu element downstream
of CGG repeat (nucleotides 18523–18804), the L1 el-
ement (nucleotides 84696–92586), and the SVA element
(nucleotides 93455–95194). Hybridization probes
flanking the elements were generated by PCR with the
following primer pairs. The probe for the Alu element
upstream of CGG repeat: forward primer (nucleotides
9881–9903) 5′-GAATGAGAGGTCATGGTTAAAGG-
3′, and reverse primer (nucleotides 10137–10159) 5′-AT-
CTGATATTGGAATGATGCTTC-3′. The probe forAlu
element downstream of CGG repeat: forward primer
(nucleotides 18823–18849) 5′-AGGAGGGATATTTT-
ACAATGCTGTAAG-3′, and reverse primer (nucleo-
tides 19277–19301) 5′-TGTGATGAGAATCTTGGA-
ATTTGAG-3′. The probe betweenL1 and SVA elements:
forward primer (nucleotides 92687 – 92710)
5′-CCTCCATCATCTCCTCTCTTAAAG-3′, and re-
verse primer (nucleotides 93216–93241) 5′-GAGGTT-
AGAATTTTGTTAGGGGAGAG-3′. PCR amplifica-
tions were carried out in 25-ml reactions with 50 ng
genomic DNA, 200 mM dNTPs, 1.5 mM MgCl2, 0.8
mM each primer, 1 # PCR buffer II (PE Biosystems),
and 1.25 U Taq DNA polymerase (Boehringer Man-
heim). Thermal cycling parameters were as follows (Stra-
tagene Robocycler): 95C for 4 min for 1 cycle; 95C
for 1 min, 62C for 1 min, and 72C for 2 min for 30
cycles; and 72C for 10 min for 1 cycle. PCR products
were purified from agarose gels (Qiagen; Qiaex II Gel
Purification Kit) and cloned (Invitrogen; TA Cloning
Kit). The cloned probes were isolated from the vector
by standard methods.
The Alu element examined on the Y chromosome is
contained within the “Homo Sapiens 5′ region ZFY gene
sequence” (Genbank accession number U00242). This
Alu element is located at nucleotides 4669–4954. The
PCR-generated probe flanking this Alu was amplified
with the following primer pair: forward primer (nucle-
otides 3594–3615) 5′-GCAGTGTCGGCTACGCTTTA-
GG-3′, and reverse primer (nucleotides 4638–4660) 5′-
GCTACCTTCTTGATCATCCATCC-3 ′ . PCR
amplification conditions were the same as described ex-
cept the annealing temperature was 66C. This probe
was also gel-purified, cloned, and then isolated from the
vector.
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Figure 2 No methylation detected with the McrBC endonucle-
ase. A, Southern-blot analysis of genomic DNA samples digested with
either PstI alone (P) or PstI followed by McrBC (Mc) and hybridized
with probe pfxa3. Genomic DNA samples were derived from two
normal males (N male), two premutation males (PM male), four full-
mutation males (FM male), and patient M.K.’s peripheral blood lym-
phocytes (M.K. pbl), fibroblasts (M.K. fibroblasts), and fibroblast
clone (M.K. fibro. clone). B, Photograph of the ethidium bromide–
stained gel, taken prior to Southern blotting.
Tissue Culture, Cell Lines, and Microcell-Mediated
Chromosome Transfer
Human fibroblast cell lines were established, with in-
formed consent, from skin biopsies of adult fragile-X
full-mutation carriers (TC38-89, M.K.) referred for clin-
ical fragile-X testing to either the Oregon Health
Sciences University DNA Diagnostic Laboratory or the
Kaiser Permanente Cytogenetics Laboratory. All human
cell cultures were maintained at 37C in 5% CO2, in a-
minimal essential media (a-MEM) supplemented with
20% FCS (JRH Biosciences), 2 mM L-glutamine, and
16 mg/ml gentamicin sulfate.
The DelTG3 mouse cell line is a thioguanine-resistant
clone isolated form the mouse P19-derived embryonal
carcinoma (EC) cell line H4D2 (Turker et al. 1989a,
1989b). The Dif6 cell line is a morphologically differ-
entiated and thioguanine-resistant derivative of H4D2
(Turker et al. 1991). All mouse cell cultures were main-
tained at 37C in 5% CO2, in Dulbecco’s Modified Ea-
gle’s Medium (DMEM) supplemented with 5% FCS and
5% serum plus (JRH Biosciences).
Whole-cell fusions were accomplished by mixing hu-
man fragile-X fibroblasts and mouse cell-line Dif6 to
obtain ratios of 1:3, 1:1, and 3:1 with a total of 3#
cells per 25-cm2 flask. After mixing, the cells were610
incubated for ∼6 h and fused, by treatment for 60 s or
80 s, with 1 ml of 50% polyethylene glycol solution
(Sigma; PEG 1,450) in a-MEM. The cultures were rinsed
three times with PBS, incubated overnight in nonselec-
tive media, and split the next day into 150-mm dishes
at a concentration of cells/dish. Selection51 2# 10
for fusion clones was applied ∼48 h post-fusion with 10
mg/ml hypoxanthine (Sigma), 10 mg/ml azaserine
(Sigma), and 1 mg/ml geneticin (Gibco BRL). Individual
fusion clones were isolated 11–14 d after initiating se-
lection and were thenmaintained inmedia supplemented
with hypoxanthine and azaserine to retain the human
X chromosome. Microcell fusions were performed es-
sentially as described by Fournier (1981). Microcells
were isolated from a whole-cell hybrid clone and fused
to DelTG3 by treatment for 60 s with a 50% PEG so-
lution in a-MEM. Selection for the human X chromo-
some was accomplished with azaserine and hypoxan-
thine. Individual microcell hybrid clones were isolated
16 d after fusion and were expanded through ∼24 pop-
ulation doublings until the cells were harvested for DNA
isolation.
Results
A Full Mutation with No CpG-Island Methylation in
DNA Isolated from Patient M.K.
Analysis of methylation at the FMR1 locus was ini-
tially performed by Southern blot with EcoRI/EagI–
digested genomic DNA derived from patient M.K.’s pe-
ripheral blood lymphocytes and cultured skin fibro-
blasts. Hybridization of the membrane with the probe
pfxa3 resulted in the expected 2.8-kb and 5.2-kb frag-
ments in a control female (fig. 1B, lane 2). The hybrid-
ization band, at 2.8 kb, represents normal unmethylated
alleles with ∼30 repeats. The 5.2-kb band represents the
same normal alleles that have a methylated EagI site due
to X chromosome inactivation (fig. 1A). Peripheral
blood DNA from the patient showed an unusual hy-
bridization pattern with a large, highly diffuse smear
ranging in size from ∼60–700 repeats (fig. 1B, lanes 3
and 4; see also fig. 2A, lane 18). DNA derived from
M.K.’s cultured skin fibroblasts produced a hybridiza-
tion pattern with less smearing, two major bands at 230
and 330 repeats, and a third, faint band at 600–650
repeats (fig. 1B, lane 5; see also fig. 2A, lane 20). Despite
most of the alleles in both tissue types falling well within
the full-mutation size range, digestion with EagI ap-
peared complete, which is consistent with a complete
lack of methylation at this site located 282 bp upstream
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of the CGG repeat (fig. 1A). Methylation at the EagI
site would have produced a hybridization pattern of
5.2 kb. Analysis of DNA samples from 37 clonal fi-
broblast lines derived from M.K.’s skin culture also re-
vealed no evidence of methylation at the EagI site (data
not shown). The allele sizes observed in these clones
occurred at frequencies proportionate to their relative
abundance in the mass culture. Most clones contained
alleles of 230–330 repeats, and some contained large
alleles of 600–650 repeats.
To assess more fully methylation levels throughout the
CGG expansion and flanking regions, DNA prepara-
tions were digested with the McrBC endonuclease com-
bination. The recognition sequence of the McrBC en-
zyme pair consists of two half-sites, each composed of
a purine followed by methylcytosine. Since only cyto-
sines within a CpG dinucleotide are eligible for meth-
ylation in mammals, an McrBC half-site can be either
AmCG or GmCG. Digestion of DNA occurs when two
half-sites are separated by 32 bp–2 kb, with optimal
separation at 55–103 bp (Stewart and Raleigh 1998).
There are 48 potential half-sites and an additional half-
site at each CGG repeat within the PstI-restriction frag-
ment that contains the repeat and most of the CpG is-
land. Analysis of methylation at the McrBC sites was
performed by Southern blot of DNA samples digested
with either PstI alone or with PstI followed by McrBC.
Hybridization was again carried out with probe pfxa3.
DNA samples derived from two control males and two
premutation males showed identical hybridization pat-
terns in samples digested with PstI alone or with PstI 
McrBC (fig. 2A, lanes 2–9). The failure of McrBC to
digest these DNA samples is consistent with an absence
of methylation. In contrast, DNA preparations from
four full-mutation males were digested completely by
McrBC, as demonstrated by the absence of hybridization
bands in these lanes (fig. 2A, lanes 11, 13, 15, and 17).
Although it is not possible to determine which specific
sites are methylated and serving as half-sites in these
samples, the absence of a hybridization signal in the PstI
 McrBC lanes is consistent with substantial methyla-
tion. A photograph of the ethidium bromide–stained gel
taken before Southern blotting shows that DNA content
in these lanes was indistinguishable from the other PstI
McrBC lanes (fig. 2B). DNA samples from the patient
were not digested byMcrBC and produced hybridization
patterns identical to those observed in the samples di-
gested with PstI alone (fig. 2A, lanes 18–23). This result
indicates that the McrBC half-sites throughout the CpG
island and within the CGG repeat are largely or com-
pletely free of methylation, although it is possible that
a single half-site is methylated, or that methylation oc-
curs at two or more sites separated by !32 bp. We note
that some of the PstI  McrBC lanes have a slightly
diminished hybridization signal compared to the lanes
containing samples digested with PstI alone. We attrib-
ute this to underloading of the PstI  McrBC samples
as a consequence of GTP in the McrBC digestion buffer,
which interfered with spectrophotometric quantitation
of the samples post-digestion.
Hypomethylation of the Expanded CGG-Repeat
Region Occurs in the Presence of Normal Methylation
of Repetitive DNA Elements
Most repetitive elements are heavily methylated in
mammalian somatic cells, and it has been suggested that
methylation of expanded FMR1 CGG repeats is due to
their resemblance to these elements (Bestor and Tycko
1996). To determine whether FMR1 hypomethylation
in patient M.K. is associated with decreasedmethylation
at repetitive DNA elements, methylation was assessed at
five repetitive-element loci. These loci were selected on
the basis of one of the following: (1) proximity to the
FMR1 CGG repeat (two Alu elements), (2) high CpG
density (an X chromosome SVA element), or (3) timing
of de novo methylation during gametogenesis and early
development (a Y chromosome Alu element and an X
chromosome L1 element). Methylation at each of the
loci was ascertained by Southern-blot analysis of ge-
nomic DNA samples digested with a methylation-sen-
sitive restriction enzyme. Hybridization probes flanking
the elements were generated by PCR as presented in the
Patient and Methods section.
Alu elements closest to the FMR1 CGG repeat are
located 4.7 kb downstream (in the middle of intron 1)
and 5.6 kb upstream. These elements each contain at
least one MspI/HpaII restriction site at which methyla-
tion can be assessed (fig. 3A and C). DNA preparations
were digested with EcoRI alone, with EcoRI  MspI,
or with EcoRI  HpaII. Hybridization with a probe
flanking the downstream Alu showed no apparentHpaII
digestion, demonstrating a high degree of methylation
at these sites in peripheral blood–lymphocyte DNA sam-
ples from normal controls (fig. 3B, lanes 4 and 7) and
four fragile-X carriers (data not shown). The hybridi-
zation pattern inM.K.’s lymphocyte and fibroblast DNA
samples are indistinguishable from that of the controls
(fig. 3B, lanes 10 and 13), indicating that this Alu ele-
ment is methylated normally in the patient. Although
most Alu elements are heavily methylated in somatic
cells (Schmid 1991), these elements are largely hypo-
methylated in sperm cells (Hellmann-Blumberg et al.
1993; Kochanek et al. 1993). As a control for probe
specificity and HpaII digestion, DNA isolated from the
sperm of a normal control was analyzed. Hybridization
in the sperm DNA EcoRI  HpaII lane demonstrated
significant HpaII digestion, consistent with markedly re-
duced methylation of bothMspI/HpaII sites (fig. 3B, lane
16). Analysis of the upstream Alu was accomplished
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Figure 3 Analysis of Alu methylation. A, Restriction map of region surrounding an Alu element 4.7 kb downstream of the FMR1 CGG
repeats. B, Southern-blot analysis of methylation at the downstream Alu, done with a PCR-generated probe and genomic DNA samples digested
with EcoRI alone (E), EcoRI and MspI (M), or EcoRI and HpaII (H). Genomic DNA samples were derived from two normal males (N male),
patient M.K.’s fibroblasts (M.K. fibro.) and peripheral blood lymphocytes (M.K. pbl), and sperm from a normal male (N male sperm). C,
Restriction map of region surrounding anAlu element located 5.4 kb upstream of the FMR1CGG repeat.D, Southern-blot analysis ofmethylation
at the upstream Alu, shown in C, done with a PCR-generated probe and the same Southern-blot membrane used in B. E, Restriction map of
the region surrounding a Y chromosome Alu near the ZFY gene. F, Methylation of the Y chromosome Alu, shown in E, done by Southern blot
of DNA samples digested with HindIII alone (H) or with HindIII and BstBI (B), and hybridized with a PCR-generated probe. DNA samples
were derived from two normal males (N males), a full-mutation male (FM male), patient M.K.’s peripheral blood lymphocytes (M.K. pbl) and
fibroblasts (M.K. fibro.), and sperm from a normal male (N male sperm).
with use of the same Southern-blot membranes, which
were stripped and hybridized to a probe flanking the
upstream element (fig. 3C). The hybridization pattern
again showed a high degree of methylation for this el-
ement in the peripheral blood–lymphocyte controls (fig.
3D, lanes 4 and 7) and the M.K. samples (fig. 3D, lanes
10 and 13). Partial methylation of anHpaII site outside
the Alu sequence was observed in M.K.’s fibroblast-de-
rived DNA (fig. 3D, lane 10), but complete methylation
at this site was observed in his lymphocyte DNA (fig.
3D, lane 13). Unlike the downstream Alu, hybridization
with the upstream Alu probe revealed a high degree of
methylation in the sperm-derived DNA (fig. 3D, lane
16).
Alu elements are inherited from the female parent in
the methylated state and from the male parent in the
unmethylated state (Schmid 1996; Yoder et al. 1997).
The paternally inherited Alu elements are methylated de
novo during early embryogenesis (Yoder et al. 1997).
To study methylation at an Alu element likely to be
subject to de novo methylation during M.K.’s devel-
opment, we assessed methylation at a Y chromosome
Alu, located upstream of the ZFY gene. DNA samples
were digested with HindIII alone or with HindIII 
BstBI (fig. 3E). Digestion with BstBI did not occur in
somatic controls or in DNA from M.K.’s lymphocytes
and fibroblasts (fig. 3F, lanes 3, 5, 7, 9, and 11). The
inability of BstBI to digest these samples is consistent
with a high degree of methylation. Sperm DNA was
completely digested with BstBI, indicating this site is
unmethylated in this tissue (fig. 3F, lane 13).
It is not known whether de novo methylation of Alu
elements and fragile-X full-mutation alleles share any
mechanistic similarities. Although both can potentially
form secondary structures, which may serve as signals
for de novo methylation, expanded fragile-X repeats are
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Figure 4 Analysis of methylation at X chromosome L1 and SVA
elements. A, Restriction map of region surrounding L1 and SVA el-
ements located ∼80 kb downstream of the FMR1 CGG repeats. B,
Southern-blot analysis was accomplished with a PCR-generated probe
and the same Southern-blot membranes used in figure 3B and D.
Partial methylation of the 21 recognition sites located in the SVA
element produces a smear, which is denoted on the restriction map by
a diagonal line.
significantly larger and more CpG dense than are Alu
elements. To assess methylation at a site that more
closely resembles an expanded fragile-X repeat, we
searched for large repetitive elements with high CpG
density near the FMR1 gene. Approximately 80 kb
downstream of the FMR1 CGG repeat is a region of
high CpG density contained within an SVA element. The
SVA element spans 1.7 kb and contains 86 (9.9%) CpG
dinucleotides, 21 of which are located in MspI/
HpaII–recognition sites. Adjacent to the SVA element is
a large L1 element that contains two additional MspI/
HpaII sites (fig. 4A). Methylation of the L1 and SVA
CpG sites was assessed with the same Southern-blot
membranes that were used for analysis of the X chro-
mosome Alu elements. Hybridization patterns in the
normal and fragile-X peripheral blood–lymphocyte con-
trols were consistent with complete methylation of both
sites in the L1 element and with near-complete meth-
ylation at the sites in the SVA element (fig. 4B, lanes 4
and 7). The hybridization pattern inM.K.’s lymphocyte-
derived DNA was indistinguishable from the controls’
(fig. 4B, lane 13). M.K.’s fibroblast-derivedDNA sample
was substantially less methylated at sites in both the L1
and SVA elements (fig. 4B, lane 10). However, the same
methylation pattern was also observed in fibroblast-de-
rived DNA from six controls, indicating that the differ-
ence between the lymphocyte and fibroblast cells is tissue
specific and not attributable to the specific conditions in
M.K.’s cells (data not shown). Sperm-derived DNA from
a normal control was completely methylated at both L1
sites and was substantially less methylated at at least
some of the SVA sites compared to the somatic controls
(fig. 4B, lane 16).
Microcell-Mediated Chromosome Transfer into Mouse
EC Cells Does Not Induce De Novo Methylation of
Hypomethylated Expanded CGG Repeats
To test whether the methylation deficiency in M.K.’s
cells could be complemented in trans, an X chromosome
bearing an unmethylated full mutation was transferred
by microcell fusion into a de novo methylation-com-
petent mouse EC cell. EC cells are capable ofmethylating
certain DNA substrates de novo, including proviral ge-
nomes (Stewart et al. 1982) and mammalian sequences
that direct the formation of methylation patterns (Turker
et al. 1991; Mummaneni et al. 1993, 1995). These se-
quences include B1-repetitive elements (P. A. Yates, R.
W. Burman, P. Mummaneni, S. Krussel, and M. S.
Tucker, unpublished data) which are homologous to the
human Alu elements (Schmid 1996). The unmethylated
full-mutation allele was transferred initially by whole-
cell fusion to a differentiated and 6-thioguanine resistant
(HPRT) mouse cell line that lacks the capacity for de
novo methylation of transfected DNA (Turker et al.
1991). Retention of the human X chromosome was se-
lected on the basis of expression of the HPRT locus,
located ∼19 Mb centromeric of the FMR1 gene. A
whole-cell hybrid containing an unmethylated expan-
sion of 350 repeats was selected as the microcell donor.
The repeat region remained unmethylated in the differ-
entiated background, which is indicated by resistance to
McrBC digestion (fig. 5, lane 9). Microcells were isolated
from the donor clone by standard procedures and fused
to DelTG3, a thioguanine-resistant derivative of the P19
EC cell line. Nine fusion clones, each of which exhibited
the undifferentiated morphology characteristic of EC
cells, were isolated. All of the microcell clones retained
the human HPRT locus, but only four of the nine re-
tained the FMR1 region indicated by Southern-blot anal-
ysis and PCR amplification of markers located between
the loci (data not shown). Despite propagation of the
chromosomes through ∼24 population doublings, the
FMR1 CpG island remained unmethylated by both
EcoRI/EagI digestion (data not shown) and PstI 
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Figure 5 Microcell-fusion clones. Methylation was analyzed by
Southern blot of DNA samples digested with PstI alone (P) or with
PstI followed by McrBC (Mc), and hybridized with probe pfxa3.Non-
polymorphic mouse-specific bands were observed at 5.6 kb and at 2.7
kb in PstI- and PstI  McrBC–digested DNA, respectively. The po-
sitions of human FMR1-specific hybridization bands with ∼850 or
∼350 repeats are indicated by arrows. Mouse DNA, derived from
cultured EC (mouse EC) or from differentiated cells (mouse differ-
entiated), shows only the presence of the mouse-specific bands (lanes
2–5). Introduction of a human fragile-X chromosome into the differ-
entiated cells by whole-cell fusion results in an additional human-
specific band in the fusion clones (lanes 6 and 8). When the human
X chromosome contains a methylated expansion (methylated FM in
differentiated mouse), it is sensitive to digestion with McrBC (lane 7).
An unmethylated expansion (unmethylated FM in differentiated
mouse) is resistant to digestion in the mouse background, indicating
that the human locus remains free of methylation in the differentiated
mouse cells (lane 9). Microcell-fusion clones in which an unmethylated
full mutation is replicated in an EC cell background (unmethylated
FM in mouse EC, by microcell fusion) are also resistant to McrBC
digestion and are thus not methylated (lanes 11, 13, 15, and 17).
McrBC digestion in each of the microcell clones (fig. 5,
lanes 11, 13, 15, and 17).
Discussion
The patient examined in this study is one of a small
group of individuals that carries FMR1 full-mutation
alleles lacking significant methylation at upstream sites
(Loesch et al. 1993; McConkie-Rosell et al. 1993; Hag-
erman et al. 1994; Merenstein et al. 1994; Rousseau et
al. 1994a, 1994b; Feng et al. 1995; Smeets et al. 1995;
de Vries et al. 1996; Lachiewicz et al. 1996; Wang et al.
1996; Wohrle et al. 1998; Taylor et al. 1999). Charac-
terization of methylation in these individuals has, in
most cases, been made on the basis of Southern-blot
analysis of genomic DNA samples digested with meth-
ylation-sensitive restriction endonucleases (usually EagI,
BssHII, and NruI). Although each of these enzymes as-
sesses methylation at only a small percentage of the CpG
dinucleotides that comprise the FMR1 CpG island, the
production of FMRP and normal protein DNA–
footprinting interactions (Schwemmle 1999) suggest that
sites throughout the promoter are also unmethylated.
Furthermore, analysis of epigenetic-methylationpatterns
with bisulfite sequencing has demonstrated that FMR1
methylation patterns are exclusive (i.e., a particular
DNA molecule will be either hypo- or hypermethylated)
(Stoger et al. 1997). We observed that M.K. carries a
mix of premutation and full-mutation alleles that are
completely unmethylated at the EagI restriction site.
Moreover, analysis with McrBC-digested DNA dem-
onstrates that most if not all CpG dinucleotides, both
within and surrounding the CGG repeats, are likewise
free of methylation. Although we cannot rule out a low
level of methylation at M.K.’s FMR1 locus, the large
majority of his DNA is clearly resistant to McrBC di-
gestion, as was detected with use of probe pfxa3.Meth-
ylation restricted to the CGG repeat is unlikely to impact
transcription of the FMR1 gene, since the known reg-
ulatory elements are located upstream (Hwu et al. 1993;
Schwemmle et al. 1997). Methylation of these repeats
is, however, relevant to both the proposed relationship
between repeat stability and methylation (Wohrle et al.
1996, 1998) and to the proposal that the expanded re-
peats are to serve as the initial target for de novo meth-
ylation (Bestor and Tycko 1996).
Most of the methylated cytosines in human DNA are
thought to reside in the 35% of the genome that is com-
posed of transposable elements, such as the Alu, L1, and
retroviral elements (Smit 1996). Although the biological
roles of cytosine methylation are subjects of debate, one
proposed function is the suppression of the transcription
of transposable or parasitic sequence elements (Liu and
Schmid 1993; Yoder et al. 1997). Therefore, these ele-
ments may act as specific targets for de novo methyla-
tion. This model predicts that the fragile-X CGG repeat
might become a target for de novo methylation when
expanded sufficiently to resemble a parasitic element. It
has been speculated that the de novo methylation spec-
ificity of the mammalian DNA methyltransferase is de-
pendent on DNA secondary structures (Bestor and Ty-
cko 1996; Bender 1998). Numerous types of secondary
structures are observed in disease-causing triplet repeats
(Sinden 1999), and, in the case of CGG repeats, three-
way hairpin–slippage structures are efficient substrates
for de novo methylation in vitro (Chen et al. 1995,
1998). The demarcation that exists in the fragile-X syn-
drome between unmethylated premutation alleles and
methylated full mutations might then represent a thresh-
old at which the CGG repeat reaches a length that allows
the formation of secondary structures resembling par-
asitic sequence elements. Alternatively, methylation of
expanded fragile-X repeats may occur randomly or in
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association with the switch to very late DNA replication
that occurs in the FMR1 region of cells that carry full
mutations (Hansen et al. 1997). A selective disadvantage
during early development for the cells that contain an
unmethylated expansion (Hansen et al. 1997) could ex-
plain the appearance of only methylated full mutations
in the cells of most adult patients with fragile-X syn-
drome.
The above discussion suggests that one explanation
for rare hypomethylated full-mutation alleles is that they
have escaped the process of de novo methylation. To test
this possibility, we have examined methylation levels at
repetitive-sequence elements that were likely to have
been subject to de novo methylation during M.K.’s early
development.MostAlu elements inherited from themale
parent are initially hypomethylated and achieve the
highly methylated state characteristic of adult somatic
cells during the wave of de novo methylation that occurs
after implantation (Yoder et al. 1997). Conversely, L1
elements are inherited from the female parent in the un-
methylated state and, like Alu elements, are subject to
de novo methylation during embryogenesis (Yoder et al.
1997). We observed that both a paternally inherited Alu
element and a maternally inherited L1 element are meth-
ylated in M.K.’s somatic cells. The presence of meth-
ylation in these elements indicates that de novo meth-
ylation occurred successfully at these sites duringM.K.’s
early development. On the basis of these findings, we
have concluded that if the FMR1 methylation abnor-
mality in M.K. is due to a defect in trans, then Alu and
L1 methylation are likely to be mediated by pathways
other than that responsible for methylation of the FMR1
CGG-repeat region. If de novo methylation of different
genomic sequences occurs with distinct enzymology, re-
petitive elements that share characteristics in common
with the fragile-X CGG repeat might be more likely to
be methylated with the same pathway. To locate such
an element, we searched for regions with high CpG den-
sity and identified a 1.7-kb SVA element, 80 kb down-
stream of the FMR1 CGG repeat that contains 86
(9.9%) CpG dinucleotides. Methylation of this element
appears to have occurred normally in M.K.’s cells, fur-
ther indicating that a generalized methylation deficiency
is not present at the elements tested.
Another possible explanation for the absence of
FMR1 CpG-island methylation in M.K. is that a fail-
ure of maintenance methylation has occurred specif-
ically in the FMR1 region. To assess this possibility,
we examined methylation levels at Alu elements flank-
ing the expanded CGG-repeat region. These Alu el-
ements were inherited maternally with high levels of
methylation that are believed to persist during the
early embryonic period characterized by dynamic
changes in global methylation patterns. The possibil-
ity of perturbed maintenance methylation as an ex-
planation for M.K.’s methylation deficiency is sug-
gested by the Arabidopsis thalianamutant, ddm1, that
exhibits a reduction in genomic cytosine methylation,
which occurs first in repeated sequences (Vongs et al.
1993; Kakutani et al. 1996; Jeddeloh et al. 1998). One
model of DDM1 function is that it acts as a part of
a nucleosome-remodeling complex that increases ac-
cessibility of the DNA to the maintenance methyl-
transferase (Jeddeloh et al. 1999). This is a particu-
larly attractive model when applied to the fragile-X
CGG repeats because it predicts that preferential hy-
pomethylation of sequences that exist in highly con-
densed chromatin, such as fragile-X full mutations
(Luo et al. 1993; Eberhart and Warren 1996; Godde
et al. 1996; Wang and Griffith 1996), can result from
a mutation in trans. However, it seems unlikely that
an explanation for M.K.’s unmethylated full mutation
will be found at the level of an FMR1 region-specific
abnormality in maintenance methylation, because the
two Alu elements flanking the CGG repeat, at a dis-
tance of ∼5 kb, are maintained with a high level of
methylation.
Alternatively, M.K.’s full mutation may have escaped
the methylation process, not on the basis of a failure of
de novo or maintenance methylation, but, rather, as a
result of the timing of repeat expansion during early
development. The ability to de novo methylate DNA
substrates is primarily a characteristic of embryonic cells
(Jaenisch 1997). It is possible that, during the embryonic
period characterized by cellular de novo methylation
competence, M.K. carried an allele that failed to serve
as a substrate for methylation due to its size in the upper-
premutation range. If this allele expanded after the pe-
riod of de novo methylation was complete, then it might
thereafter remain unmethylated despite attaining the size
of a typical full mutation (Wohrle et al. 1998). This
possibility is supported by studies that have demon-
strated that unmethylated alleles are unstable in cultured
fibroblasts (Wohrle et al. 1998; Glaser et al. 1999; Bur-
man et al., in press).
To date, the only inherited defect in genomic meth-
ylation identified is the ICF (immunodeficiency, cen-
tromeric instability, and facial anomalies) syndrome
(MIM 242860). The ICF syndrome is a rare autosomal
recessive condition that is characterized by chromosomal
abnormalities and reduced methylation in repeated sat-
ellite regions and in some Alu elements (Miniou et al.
1997a, 1997b). Cell-fusion experiments have shown that
this defect can be at least partially complemented in trans
(Schuffenhauer et al. 1995). To test directly whether the
FMR1-specific methylation deficiency in patient M.K.
could be complemented in trans,we introduced the chro-
mosome bearing this allele into mouse EC cells. These
cells have a high capacity to de novo methylate trans-
fected DNA (Turker et al. 1991) and also have the ability
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to methylate target sequences introduced by microcell-
mediated chromosome transfer (P. A. Yates and M. S.
Turner, unpublished data). One target for de novo meth-
ylation is the mouse B1 element (P. A. Yates, R. W. Bur-
man, P. Mummaneni, S. Krussel, and M. S. Tucker, un-
published data), which is homologous to the human Alu
element (Schmid 1996). We found no evidence of meth-
ylation by using either the EagI-restriction assay or the
McrBC assay in DNA prepared from microcell hybrids,
which had replicated patient M.K.’s X chromosome∼24
times. Several explanations can be invoked to describe
this result. One possibility is that expanded CGG repeats
do not serve as a methylation signal in the EC cells
utilized and/or they have not formed the secondary struc-
ture that is required for de novo methylation to occur.
Alternatively, M.K.’s chromosome may contain some
type of variation in cis that renders his repeat unrecog-
nizable as a target or that is otherwise inherently resis-
tant to de novo methylation. However, the presence of
a cousin with a methylated expansion of presumably the
same allele argues against these latter possibilities, unless
a distinct genetic alteration occurred in patient M.K.
Finally, the lack of methylation at the transferred allele
may simply reflect an inherent difference in the way
mouse and human cells maintain/metabolize large CGG
repeats. Additional work will be required to sort through
these possibilities.
To summarize, we have described a patient with a fully
expanded fragile-X mutation lacking EagI-site methy-
lation. Analysis with the McrBC endonuclease demon-
strated further that the CGG repeat and ∼1 kb of sur-
rounding DNA are also free of methylation.Methylation
patterns are formed normally at Alu elements within 5
kb of the repeat and at other repetitive-element loci on
the X and Y chromosomes. These results suggest that
hypomethylation of the expanded FMR1 CGG-repeat
region is not due to global or regional defects in de novo
or in maintenance methylation processes. Whether this
deficit represents a rare stochastic event or a rare herit-
able alteration remains to be determined.
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